Pentoxifylline


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
1277 COL1A1 Decreases expression PMID:11788567; PMID:14993492; PMID:7617123
1281 COL3A1 Decreases expression PMID:11788567
1401 CRP Decreases expression PMID:14970111
1490 CCN2 Decreases expression PMID:11788567
1544 CYP1A2 Decreases activity PMID:11465391
1647 GADD45A Increases expression PMID:18851957
2353 FOS Increases expression PMID:18851957
3162 HMOX1 Decreases expression PMID:22461696
3383 ICAM1 Decreases expression PMID:14993492
355 FAS Affects expression PMID:14970111; PMID:18851957
3559 IL2RA Decreases expression PMID:1709825; PMID:25433234
3565 IL4 Increases expression PMID:7589090
3569 IL6 Decreases expression PMID:12419648
4170 MCL1 Increases expression PMID:18851957
43 ACHE Decreases activity PMID:11981227
4879 NPPB Decreases expression PMID:14970111
5243 ABCB1 Decreases expression PMID:33775688
5599 MAPK8 Increases expression PMID:20804743
5601 MAPK9 Increases expression PMID:20804743
59 ACTA2 Decreases expression PMID:14996430
598 BCL2L1 Decreases expression PMID:18851957
6347 CCL2 Decreases expression PMID:14993492
6352 CCL5 Decreases expression PMID:14993492
6696 SPP1 Decreases expression PMID:14993492
7039 TGFA Decreases expression PMID:11843059
7040 TGFB1 Decreases expression PMID:11788567
7042 TGFB2 Increases expression PMID:11843059
7076 TIMP1 Increases expression PMID:11788567
7124 TNF Affects expression PMID:10996031; PMID:11508396; PMID:14970111; PMID:8741040; PMID:14993492; PMID:1593221; PMID:7769305
7412 VCAM1 Decreases expression PMID:14720322
7422 VEGFA Decreases expression PMID:14720322
836 CASP3 Increases activity PMID:18851957
8743 TNFSF10 Increases expression PMID:18851957
8795 TNFRSF10B Increases expression PMID:20804743
8797 TNFRSF10A Increases expression PMID:20804743
8837 CFLAR Decreases expression PMID:18851957
969 CD69 Decreases expression PMID:25433234

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.